{"id":25402,"date":"2026-06-17T15:57:04","date_gmt":"2026-06-17T18:57:04","guid":{"rendered":"https:\/\/icaro.med.br\/?p=25402"},"modified":"2026-06-17T18:32:56","modified_gmt":"2026-06-17T21:32:56","slug":"mebendazole-and-cancer","status":"publish","type":"post","link":"https:\/\/icaro.med.br\/en\/mebendazole-and-cancer\/","title":{"rendered":"Does Mebendazole have an effect on cancer? YES!"},"content":{"rendered":"

Mebendazole and Its Mechanisms of Action in Tumor Cells<\/strong><\/p>\n\n\n\n

Mebendazole (MBZ) does not act in just one way: it is considered a \u201cmulti-target\u201d drug (multi-target<\/em>). Based on robust scientific literature (studies in vitro<\/em>, in vivo<\/em> and early clinical trials), I detail below the main sites and mechanisms of action of mebendazole in tumor cells:<\/p>\n\n\n\n

1. Microtubule destabilization (the primary mechanism)<\/strong><\/p>\n\n\n\n

Just as MBZ interferes with the microtubule dynamics of parasites, studies show that it can also interfere with the microtubule dynamics of tumor cells.<\/p>\n\n\n\n

\u2705 Location:<\/strong> MBZ binds specifically to beta-tubulin in tumor cells, often at the same binding site as colchicine.<\/p>\n\n\n\n

\u2705 The mechanism:<\/strong> Cancer cells need to build microtubules\u2014a kind of cellular \u201cskeleton\u201d and \u201ctrack\u201d\u2014in order to divide and multiply rapidly. By binding to beta-tubulin, mebendazole prevents the polymerization of these microtubules.<\/p>\n\n\n\n

\u2705 The result:<\/strong> The tumor cell may be unable to complete mitosis (cell division), resulting in cell cycle arrest in the G2\/M phase, which often leads to apoptosis or other forms of cell death.<\/p>\n\n\n\n

<\/div>\n\n\n\n

2. Inhibition of angiogenesis (leading to a disruption of the blood supply)<\/strong><\/p>\n\n\n\n

Tumors need to create new blood vessels (angiogenesis) to receive oxygen and glucose and continue growing.<\/p>\n\n\n\n

\u2705 Location:<\/strong> Vascular endothelial growth factor receptors, particularly VEGFR2.<\/p>\n\n\n\n

\u2705 The mechanism:<\/strong> Studies show that MBZ inhibits VEGFR2 signaling and reduces the formation of new capillaries around and within the tumor.<\/p>\n\n\n\n

\u2705 The result:<\/strong> Reduced angiogenesis may contribute to a decreased supply of oxygen and nutrients to the tumor, limiting its growth and potential for spread.<\/p>\n\n\n\n

<\/div>\n\n\n\n

3. Induction of apoptosis (programmed cell death)<\/strong><\/p>\n\n\n\n

Cancer cells are \u201cimmortal\u201d because they \u201cturn off\u201d the natural mechanism of cell suicide (apoptosis). Mebendazole helps to reactivate this system.<\/p>\n\n\n\n

\u2705 Location:<\/strong> Mitochondria in tumor cells and proteins of the Bcl-2 family.<\/p>\n\n\n\n

\u2705 The mechanism:<\/strong> MBZ promotes the depolarization of the mitochondrial membrane, stimulating the release of cytochrome c. This activates a cascade of \u201cexecutioner\u201d enzymes called caspases, particularly caspase-3 and caspase-9.<\/p>\n\n\n\n

\u2705 The result:<\/strong> The activation of caspases triggers an organized process of programmed cell death, leading to the controlled fragmentation of the tumor cell\u2014in a clean manner, without causing excessive inflammation in the surrounding healthy tissues, compared to necrosis.<\/p>\n\n\n\n

<\/div>\n\n\n\n

4. Blocking critical signaling pathways (Hedgehog, BRAF, and MEK)<\/strong><\/p>\n\n\n\n

Some cancers rely on overactive cellular signaling pathways to survive.<\/p>\n\n\n\n

\u2705 Hedgehog (Hh) pathway:<\/strong> It is highly active against cancers such as medulloblastoma, a brain tumor. Mebendazole works by affecting factors associated with this pathway, such as the GLI1 protein, thereby helping to suppress tumor growth.<\/p>\n\n\n\n

\u2705 Kinase inhibition:<\/strong> Preclinical studies suggest that MBZ may modulate signaling pathways related to BRAF, MEK, and other kinases involved in tumor survival. Mutations in these pathways are the \u201cdriving force\u201d behind various melanomas and colorectal cancers.<\/p>\n\n\n\n

\u2705 The mechanism:<\/strong> MBZ acts almost like a targeted therapy, inhibiting the phosphorylation of these proteins and reducing signals that promote tumor proliferation.<\/p>\n\n\n\n

\u2705 The result:<\/strong> Slower growth, survival, and adaptability of cancer cells.<\/p>\n\n\n\n

<\/div>\n\n\n\n

5. Reprogramming of the Tumor Microenvironment and Immunity<\/strong><\/p>\n\n\n\n

The metabolic approach emphasizes that cancer is not just a genetic problem, but also a problem related to the cell's surrounding environment.<\/p>\n\n\n\n

\u2705 The mechanism:<\/strong> There is evidence that mebendazole helps polarize macrophages\u2014immune cells\u2014in the tumor microenvironment. Experimental studies suggest that it may promote the polarization of M2-type macrophages\u2014which protect the tumor and promote its growth\u2014into M1-type macrophages, which attack the tumor.<\/p>\n\n\n\n

\u2705 The result:<\/strong> The patient's own immune system becomes more effective at recognizing and fighting malignant cells.<\/p>\n\n\n\n

<\/div>\n\n\n\n

The Perspective of Metabolic and Integrative Oncology<\/strong><\/p>\n\n\n\n

When we follow the \u201cmetabolic approach\u201d to understanding cancer, we view mebendazole not only as a cytotoxic agent, but also as a tool with the potential to target multiple biological vulnerabilities of cancer.<\/p>\n\n\n\n

Because MBZ crosses the blood-brain barrier and reaches the brain, it has been investigated in several clinical and preclinical studies for glioblastoma, one of the most aggressive brain tumors, and is often used in combination with the standard treatment, temozolomide.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

\u26a0\ufe0f Clinical note:<\/strong> Although there is a considerable body of scientific literature describing the antitumor mechanisms of mebendazole in experimental models and early clinical studies, conventional oncology still considers it an adjuvant therapy or a therapy under investigation (off-label<\/em>).<\/p>\n\n\n\n

The dosage for cancer is different from that used for parasites; it is generally administered continuously and in higher doses, which requires close medical supervision to monitor liver toxicity (liver function).<\/p>\n\n\n\n

It is important to note that most of the mechanisms described above were observed in laboratory studies (in vitro<\/em>) and in animal models, although definitive confirmation of these effects in humans still depends on larger clinical studies.<\/strong><\/p>\n\n\n\n

<\/div>\n\n\n\n
\n

\u26a0\ufe0f IMPORTANTE<\/strong><\/p>\n\n

As informa\u00e7\u00f5es, textos e imagens desta publica\u00e7\u00e3o t\u00eam finalidade exclusivamente educativa e informativa.<\/p>\n\n

Este conte\u00fado n\u00e3o constitui consulta m\u00e9dica, diagn\u00f3stico, prescri\u00e7\u00e3o, recomenda\u00e7\u00e3o individualizada de tratamento, nem incentivo \u00e0 automedica\u00e7\u00e3o<\/strong>.<\/p>\n\n

A exist\u00eancia de estudos cient\u00edficos, mecanismos de a\u00e7\u00e3o descritos na literatura ou resultados observados em pesquisas n\u00e3o significa, por si s\u00f3, que determinado medicamento, suplemento, subst\u00e2ncia ou estrat\u00e9gia seja adequado, necess\u00e1rio, seguro ou eficaz para todas as pessoas ou situa\u00e7\u00f5es cl\u00ednicas.<\/p>\n\n

Nenhuma pessoa deve iniciar, interromper, substituir ou modificar tratamentos m\u00e9dicos com base apenas em conte\u00fados publicados em redes sociais, sites, v\u00eddeos, livros, artigos ou materiais de divulga\u00e7\u00e3o.<\/p>\n\n

Toda decis\u00e3o relacionada \u00e0 sa\u00fade deve ser tomada ap\u00f3s avalia\u00e7\u00e3o individualizada com um m\u00e9dico habilitado, considerando riscos, benef\u00edcios, hist\u00f3rico cl\u00ednico, h\u00e1bitos de vida, exames, medicamentos em uso e as caracter\u00edsticas espec\u00edficas de cada paciente.<\/p>\n\n

Meu objetivo ao compartilhar este conte\u00fado \u00e9 exclusivamente divulgar conhecimento cient\u00edfico, estimular o pensamento cr\u00edtico e contribuir para que mais pessoas tenham acesso a informa\u00e7\u00f5es de qualidade sobre sa\u00fade.<\/p>\n\n

Compartilho aqui os frutos dos meus estudos, leituras e atualiza\u00e7\u00f5es cient\u00edficas recentes, sempre com a inten\u00e7\u00e3o de ajudar as pessoas a compreenderem melhor temas relacionados \u00e0 sa\u00fade e, assim, participarem de forma mais consciente das decis\u00f5es sobre seus cuidados m\u00e9dicos.<\/p>\n\n

Fiquemos todos com Deus.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

O mebendazol e seus mecanismos de a\u00e7\u00e3o em c\u00e9lulas tumorais O mebendazol (MBZ) n\u00e3o atua de uma \u00fanica forma: ele \u00e9 considerado uma droga de \u201calvos m\u00faltiplos\u201d (multi-target). Baseado na literatura cient\u00edfica robusta (estudos in vitro, in vivo e ensaios cl\u00ednicos iniciais), detalho abaixo os principais locais e mecanismos de a\u00e7\u00e3o do mebendazol nas c\u00e9lulas […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[317],"tags":[],"class_list":["post-25402","post","type-post","status-publish","format-standard","hentry","category-cancer"],"acf":[],"_links":{"self":[{"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/posts\/25402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/comments?post=25402"}],"version-history":[{"count":4,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/posts\/25402\/revisions"}],"predecessor-version":[{"id":25407,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/posts\/25402\/revisions\/25407"}],"wp:attachment":[{"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/media?parent=25402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/categories?post=25402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/icaro.med.br\/en\/wp-json\/wp\/v2\/tags?post=25402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}